Related Articles
Survivin, Ki‑67 and tumor grade as predictors of response to docetaxel‑based neoadjuvant chemotherapy in locally advanced breast cancer
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB
LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A MULTIMODAL THERAPY INCLUDING ALTERNATING NEOADJUVANT CHEMOTHERAPY, SURGERY AND RADIOTHERAPY
Neoadjuvant chemotherapy for primary invasive ductal carcinoma of the nipple: A case report